Literature DB >> 3158522

Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition.

B Norrman, P Wallén, M Rånby.   

Abstract

The rate of 'Glu'-plasminogen activation by tissue plasminogen activator was repeatedly determined during a fibrinolytic process. The process was found to proceed via two distinct phases. The kinetics of each phase obeyed Michaelis-Menten equation: First phase; kcat about 0.17 s-1 and Km about 1 microM, second phase; kcat about 0.13 s-1 and Km about 0.06 microM. Practically identical results were obtained with one-chain as with two-chain tissue plasminogen activator. Transition from first to second phase occurred when the system had been exposed to a certain degree of plasmin digestion. Electrophoretic analysis demonstrated time correlation between the appearance of minimally degraded fibrin (X-fragments) and the transition. No such correlation was found between transition and conversion of 'Glu'-plasminogen to 'Lys'-plasminogen. The effect can result in an acceleration (up to 13-fold) of the fibrinolytic process once a slight degradation of the fibrin has taken place. In vivo, the effect described may constitute a mechanism that protects a fibrin clot from premature lysis.

Mesh:

Substances:

Year:  1985        PMID: 3158522     DOI: 10.1111/j.1432-1033.1985.tb08911.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.

Authors:  N Hudson; F E Murray; A T Cole; B Filipowicz; C J Hawkey
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Pathophysiology and prevention of postoperative peritoneal adhesions.

Authors:  Willy Arung; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

3.  Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.

Authors:  Tanya M Binette; Fletcher B Taylor; Glenn Peer; Laszlo Bajzar
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

Review 4.  Postoperative Abdominal Adhesions: Clinical Significance and Advances in Prevention and Management.

Authors:  Demetrios Moris; Jeffery Chakedis; Amir A Rahnemai-Azar; Ana Wilson; Mairead Marion Hennessy; Antonios Athanasiou; Eliza W Beal; Chrysoula Argyrou; Evangelos Felekouras; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-06       Impact factor: 3.452

5.  Kinetic studies on the effect of heparin and fibrin on plasminogen activators.

Authors:  R Fears
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

Review 6.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

7.  The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.

Authors:  D Rouy; E Anglés-Cano
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

8.  Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.

Authors:  R Bauer; S L Hansen; G Jones; E Suenson; S Thorsen; L Ogendal
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

Review 9.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

10.  Structural requirements of position A alpha-157 in fibrinogen for the fibrin-induced rate enhancement of the activation of plasminogen by tissue-type plasminogen activator.

Authors:  J G Schielen; H P Adams; M Voskuilen; G J Tesser; W Nieuwenhuizen
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.